Core Insights - The Charles Schwab Corporation reported a revenue of $5.6 billion for the quarter ended March 2025, marking an 18.1% increase year-over-year, with an EPS of $1.04 compared to $0.74 in the same quarter last year, exceeding the Zacks Consensus Estimate of $5.52 billion by 1.48% and delivering an EPS surprise of 4% [1] Financial Performance Metrics - Total client assets reached $9,929.7 billion, slightly below the average estimate of $10,139.62 billion from seven analysts [4] - The net interest margin was reported at 2.5%, aligning with the average estimate based on six analysts [4] - Daily average trades totaled 7.39 million, surpassing the average estimate of 6.78 million from five analysts [4] - Average interest-earning assets were $427.27 billion, slightly above the average estimate of $426.55 billion from five analysts [4] Revenue Breakdown - Net interest revenue was $2.71 billion, exceeding the average estimate of $2.62 billion from eight analysts, representing a year-over-year increase of 21.2% [4] - Asset management and administration fees generated $1.53 billion, slightly above the average estimate of $1.52 billion from seven analysts, reflecting a 13.5% year-over-year change [4] - Other net revenues amounted to $210 million, surpassing the average estimate of $176.64 million from seven analysts, with a year-over-year increase of 32.1% [4] - Bank deposit account fees were reported at $245 million, below the average estimate of $255.68 million from seven analysts, with a year-over-year increase of 33.9% [4] - Trading revenue was $908 million, slightly below the average estimate of $919.52 million from seven analysts, with an 11.1% year-over-year increase [4] - Mutual Fund OneSource and other non-transaction fee funds generated $222 million, exceeding the average estimate of $216.19 million from three analysts, reflecting a 6.2% year-over-year increase [4] - Schwab equity and bond funds, ETFs, and collective trust funds (CTFs) generated $122 million, slightly below the average estimate of $126.13 million from three analysts, with a 14% year-over-year increase [4] - Schwab money market funds generated $418 million, exceeding the average estimate of $410.17 million from three analysts, representing a 24.4% year-over-year increase [4]

Core Insights - Charles Schwab's first-quarter 2025 adjusted earnings were $1.04 per share, exceeding the Zacks Consensus Estimate of $1.00, marking a 41% year-over-year increase [1] - The company's shares rose nearly 4.5% in pre-market trading due to better-than-expected results [1] - The asset management business significantly contributed to revenue growth, alongside higher net interest revenues and solid brokerage account numbers, although increased expenses posed a challenge [1] Financial Performance - Net income on a GAAP basis was $1.91 billion or 99 cents per share, up from $1.36 billion or 68 cents per share in the same quarter last year, surpassing the projected $1.77 billion [2] - Quarterly net revenues reached $5.6 billion, an 18% increase year over year, exceeding the Zacks Consensus Estimate of $5.52 billion [3] - Total non-interest expenses increased by 7% to $3.14 billion, slightly above the projected $3.11 billion, while adjusted total expenses rose 8% year over year to $3.01 billion [3] Profitability Metrics - The pre-tax profit margin improved to 43.8% from 37.9% in the prior-year quarter [4] - Average interest-earning assets decreased by 2% to $427.3 billion, slightly below the estimate of $430.95 billion [4] - The annualized return on equity was 18%, up from 15% in the prior-year quarter [4] Client Metrics - As of March 31, 2025, total client assets were $9.93 trillion, reflecting a 9% year-over-year increase [5] - The company attracted net new assets of $132.4 billion during the quarter and added 1.18 million new brokerage accounts, bringing the total to 37 million active brokerage accounts [5] Capital Distribution - Schwab announced an 8% increase in its quarterly dividend to 27 cents per share during the reported quarter [6] - The company repurchased 19.2 million shares for $1.5 billion related to The Toronto-Dominion Bank's secondary offering [6] Strategic Outlook - A decline in funding costs and lower rates are expected to support Schwab's margins, along with strategic acquisitions and increased advice solution fees [7] - However, rising expenses and near-term macroeconomic challenges are identified as potential headwinds [7]

分组1 - Charles Schwab Corporation reported quarterly earnings of $1.04 per share, exceeding the Zacks Consensus Estimate of $1 per share, and up from $0.74 per share a year ago, representing an earnings surprise of 4% [1] - The company posted revenues of $5.6 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.48%, compared to $4.74 billion in the same quarter last year [2] - Over the last four quarters, Charles Schwab has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] 分组2 - The stock has increased approximately 2.3% since the beginning of the year, while the S&P 500 has declined by 10.3% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.03 on revenues of $5.53 billion, and for the current fiscal year, it is $4.20 on revenues of $22.47 billion [7] 分组3 - The Zacks Industry Rank indicates that the Financial - Investment Bank sector is currently in the bottom 33% of over 250 Zacks industries, which may impact stock performance [8] - The estimate revisions trend for Charles Schwab is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]

Group 1: Company Highlights - AbbVie Inc. has outperformed the Zacks Large Cap Pharmaceuticals industry over the past year with a growth of +10.2% compared to the industry's decline of -12.5%. The company's products, Skyrizi and Rinvoq, are performing well due to new approvals, and robust revenue growth is expected in 2025 following the loss of exclusivity for Humira [4][5] - The TJX Companies, Inc. has outperformed the Zacks Retail – Discount Stores industry over the last six months with a growth of +11.2% compared to +2.2% for the industry. The company benefits from a strong focus on customer experience and consistent increases in customer transactions [5][6] - The Charles Schwab Corp. has underperformed the Zacks Financial – Investment Bank industry over the past six months, with a growth of +5.3% compared to +19.8% for the industry. The company is facing increased expenses due to investments in growth areas and subdued trading revenues [6][7] - Enzo Biochem, Inc. has significantly underperformed the Zacks Medical – Biomedical and Genetics industry over the past year, with a decline of -69.6% compared to -12.6% for the industry. The company faces challenges from market demand and pricing pressures, along with sustained net losses [7][8] - CVD Equipment Corp. has outperformed the Zacks Manufacturing – General Industrial industry over the last six months with a decline of -8.9% compared to -15.2% for the industry. Innovations in products position the company for growth in high-demand markets, despite facing challenges from market overcapacity and fluctuating revenues [8][9] Group 2: Market Trends and Challenges - AbbVie faces near-term headwinds including biosimilar erosion of Humira, competitive pressure on Imbruvica, and slow market growth for Juvederm fillers in the U.S. and China [5] - TJX is experiencing concerns over increased store wage and payroll costs, as well as negative impacts from unfavorable currency translations [6] - Charles Schwab's subdued trading revenues raise concerns due to volatile capital market performance, although opportunistic acquisitions have led to a rise in client assets [7] - Enzo Biochem's long-term recovery is challenged by compliance costs and increased competition, which threaten operational resilience amid macroeconomic issues [8] - CVD Equipment faces challenges from silicon carbide market overcapacity and declining liquidity, which pressure margins in the volatile semiconductor sector [9]

Core Viewpoint - Charles Schwab is expected to report strong year-over-year growth in earnings and revenues for the first quarter of 2025, with key factors contributing to this performance being solid trading revenues, net interest revenues, and asset management fees [1][12]. Group 1: Earnings and Revenue Expectations - The consensus estimate for Schwab's first-quarter earnings is 99 cents per share, reflecting a 33.8% increase from the previous year [12]. - The consensus estimate for sales is $5.49 billion, indicating a 15.8% rise year-over-year [12]. Group 2: Factors Influencing Performance - Trading revenues are projected to increase by 13% year-over-year to $922.9 million, driven by solid client activity amid market volatility and economic conditions [5][4]. - Net interest revenues are expected to grow by 17.1% year-over-year to $2.62 billion, supported by higher yields on interest-earning assets despite a slight decline in average interest-earning assets [7][6]. - Asset management and administration fees are anticipated to rise by 13.2% to $1.53 billion, bolstered by strong equity market performance and growth in client assets [8]. Group 3: Expense Outlook - Schwab's operating expenses are projected to increase by 5.9% year-over-year to $3.11 billion, influenced by regulatory spending, strategic acquisitions, and marketing efforts [9]. Group 4: Earnings Surprise History - Schwab has a strong earnings surprise history, having surpassed the Zacks Consensus Estimate in three of the last four quarters, with an average beat of 4.07% [3]. Group 5: Earnings ESP and Zacks Rank - The Earnings ESP for Schwab is +0.36%, and it currently holds a Zacks Rank of 3, indicating a favorable outlook for beating earnings estimates [11][10].

Group 1: Company Performance - Charles Schwab Corporation (SCHW) shares increased by 7.6% to close at $75.25, following a period of 3.5% loss over the past four weeks [1] - The stock's rally was supported by strong trading volume, indicating heightened investor interest [1] - The company is expected to report quarterly earnings of $0.99 per share, reflecting a year-over-year increase of 33.8%, with revenues projected at $5.48 billion, up 15.7% from the previous year [3] Group 2: Market Sentiment and External Factors - The surge in Charles Schwab shares was influenced by President Donald Trump's announcement of a 90-day suspension on tariffs for non-retaliating countries, which alleviated trade tensions and improved overall market sentiment [2] - The consensus EPS estimate for Charles Schwab has been revised 1% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Group 3: Industry Context - Charles Schwab is part of the Zacks Financial - Investment Bank industry, where Piper Sandler Companies (PIPR) also operates, having seen a 14% increase in its stock price recently [4] - Piper Sandler's consensus EPS estimate remains unchanged at $2.42, representing a year-over-year decline of 13.3% [5]

Core Viewpoint - Charles Schwab Corporation (NYSE:SCHW) has received an upgrade from Morgan Stanley to "overweight" amid recession fears, although the price target was cut from $91 to $76 [1] Group 1: Analyst Ratings and Price Targets - Citigroup recently upgraded SCHW to "buy," highlighting the firm's growth potential as it "shifts to offense" [2] - Among 23 analysts covering SCHW, 18 have a "buy" or better rating, with a 12-month consensus price target of $86.89, representing a 17% premium to current levels [2] Group 2: Stock Performance - SCHW has recently experienced a sharp pullback, hitting its lowest level since October, but has since reclaimed support at the $72 level and the 320-day moving average [3] - The stock has returned to the positive side of its year-to-date breakeven [3] Group 3: Options Trading - Options trading appears favorable for SCHW, with a Schaeffer's Volatility Scorecard (SVS) of 87 out of 100, indicating it has outperformed options traders' volatility expectations over the past year [4]

Core Viewpoint - Citigroup upgraded Charles Schwab Corp from "neutral" to "buy," raising the price target from $85 to $102, citing improving growth and balance sheet metrics as the company shifts to offense [1] Group 1: Analyst Ratings and Price Targets - A majority of analysts are bullish on Charles Schwab, with 17 out of 23 firms rating it "buy" or better, and a 12-month consensus price target of $89.42, representing a 14.4% premium to current levels [2] - The stock is currently bouncing off the $76 level, which has been a significant line of pressure and support over the past few years [2] Group 2: Stock Performance and Volatility - Charles Schwab's stock has been volatile since reaching a two-year high of $84.50 on February 11, but it still shows a 5.7% year-to-date gain [2] Group 3: Options Activity - There has been a notable increase in call options for Charles Schwab, with a 10-day call/put volume ratio of 3.97, ranking higher than 96% of readings from the past year [3]

Core Insights - The article compares The Charles Schwab Corporation (SCHW) and MarketAxess (MKTX) to identify which stock presents a better value opportunity for investors [1] Valuation Metrics - SCHW has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while MKTX has a Zacks Rank of 3 (Hold) [3] - SCHW's forward P/E ratio is 18.66, significantly lower than MKTX's forward P/E of 28.15 [5] - SCHW has a PEG ratio of 0.97, while MKTX's PEG ratio is much higher at 4.99, suggesting SCHW is more reasonably priced relative to its expected earnings growth [5] - SCHW's P/B ratio stands at 3.58, compared to MKTX's P/B of 5.89, further indicating that SCHW is undervalued [6] - Based on these metrics, SCHW holds a Value grade of B, whereas MKTX has a Value grade of F, highlighting SCHW's superior valuation [6] Conclusion - Given the stronger estimate revision activity and more attractive valuation metrics, SCHW is positioned as the superior option for value investors at this time [7]

Group 1 - Zacks Premium offers various tools to help investors become more confident and informed, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] - The Zacks Style Scores rate stocks based on value, growth, and momentum characteristics, providing complementary indicators to the Zacks Rank [3][4] - Stocks are rated from A to F, with A indicating a higher chance of outperforming the market [4] Group 2 - The Value Score identifies attractive and discounted stocks using ratios like P/E and Price/Sales [4] - The Growth Score focuses on a company's financial strength and future outlook, assessing projected and historical earnings [5] - The Momentum Score helps investors capitalize on price trends, using factors like one-week price change [6] Group 3 - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stock selection [7] - The Zacks Rank utilizes earnings estimate revisions to assist investors in building successful portfolios, with 1 (Strong Buy) stocks averaging a +25.41% annual return since 1988 [8][9] - To maximize returns, investors should consider stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [11] Group 4 - The Charles Schwab Corporation (SCHW) is a savings and loan holding company offering various financial services, with nearly 400 branches across multiple locations [13] - SCHW holds a Zacks Rank of 2 (Buy) and a VGM Score of B, with a Growth Style Score of B forecasting a 29.9% year-over-year earnings growth for the current fiscal year [14] - SCHW has seen nine analysts revise their earnings estimates higher, with the Zacks Consensus Estimate increasing to $4.22 per share [14][15]